2012
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery Cortés J, Caralt M, Delaloge S, et al (Vall d'Hebron Univ Hosp, Barcelona, Spain; Institut Gustave Roussy, Villejuif Cedex, France; et al) Eur J Cancer 48:475-481, 2012§
Dominici L, Golshan M. Safety of bevacizumab in metastatic breast cancer patients undergoing surgery Cortés J, Caralt M, Delaloge S, et al (Vall d'Hebron Univ Hosp, Barcelona, Spain; Institut Gustave Roussy, Villejuif Cedex, France; et al) Eur J Cancer 48:475-481, 2012§. Breast Diseases A Year Book Quarterly 2012, 23: 351-352. DOI: 10.1016/j.breastdis.2012.09.015.Peer-Reviewed Original Research
2010
Randomized phase II trial of adding carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel and dose-dense AC in triple-negative breast cancer.
Sikov W, Perou C, Golshan M, Collyar D, Berry D, Hahn O, Singh B, Hudis C, Winer E. Randomized phase II trial of adding carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel and dose-dense AC in triple-negative breast cancer. Journal Of Clinical Oncology 2010, 28: tps110-tps110. DOI: 10.1200/jco.2010.28.15_suppl.tps110.Peer-Reviewed Original Research